The US Patent Office Grants BIOMARK Additional Patent for its LIQUID BIOPSY Technology


THE US PATENT OFFICE GRANTS BIOMARK ADDITIONAL PATENT FOR ITS LIQUID BIOPSY TECHNOLOGY Vancouver, British Columbia – (September 20, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that the US […]

Cancer that went undetected during the pandemic an ‘impending disaster,’ specialists warn

cancer that went undetected during the pandemic an impending disaster specialists warn

Screening tests and diagnostic procedures for some cancers dropped off sharply during the first COVID-19 wave Leah Hendry · CBC News · Posted: Feb 02, 2021 4:00 AM ET | Last Updated: February 2 Cancer specialists are bracing for a wave of patients suffering from more advanced disease due to delays in both screening and diagnostic testing during the pandemic. About 60,000 […]

Missing cancer cases a worrying pandemic trend

missing cancer cases a worrying pandemic trend

Elizabeth PaynePublishing date:Feb 04, 2021  Fewer Canadians have been diagnosed with cancer during the COVID-19 pandemic compared with previous years. Far from being something to celebrate, it is part of a global trend that is raising alarm bells. Across Canada, diagnoses are down by around 16 per cent overall and as much as 25 per […]


biomakrs liquid biopsy scientific paper to be featured on cover on cancers upcoming issue

Vancouver, British Columbia – (August 19th, 2019) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that the article “Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study” will be on cover of Cancers. Rashid Ahmed, President and CEO, says, “This latest paper […]

Cancer risk in families

cancer risk in families

If you have family members with cancer, you may wonder if you are at risk of developing it too (if it “runs in the family”). Sometimes a gene mutation that can cause cancer is passed on to you by your parents (inherited). Cancers caused by inherited gene mutations are called inherited cancers. And sometimes cancer […]

About Glioblastoma (GBM)

about glioblastoma gbm

Overview Tumour Group: Gliomas WHO Grade: Grade IV Prevalence/Incidence: The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and 50 to 60 per cent of astrocytic tumours. GBMs increase in frequency with age, and affect […]

Lung Cancer Screening in Real World Has High False-Positive Rate

lung cancer screening in real world has high false positive rate

By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and screened patients using low-dose computed tomography (LDCT). Over 2100 patients who were eligible for screening based […]

Opportunities and challenges for lung cancer screening in China

Opportunities and challenges for lung cancer screening in China

Chuanli Ren, Chongxu Han Abstract China accounts for nearly half of the incidence and mortality of lung cancer in the world. Furthermore, trends in lung cancer in China are increasing younger in age and the situation is deteriorating. As a whole although screening for early lung cancer may cause a small fraction of overdiagnosis and anxiety of […]